ArticleThe New England journal of medicine2009
Statin therapy with ezetimibe or niacin in high-risk patients.
Article in The New England journal of medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.Circulation · 2020Pooled it
- Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations.Molecular therapy : the journal of the American Society of Gene Therapy · 2022Review
- Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.Drugs & aging · 2014Article
- Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.Journal of the American Heart Association · 2013Article
- Treatment of familial hypercholesterolemia: is there a need beyond statin therapy?Current atherosclerosis reports · 2012Review
- Simvastatin augments the efficacy of therapeutic angiogenesis induced by bone marrow-derived mesenchymal stem cells in a murine model of hindlimb ischemia.Molecular biology reports · 2012Article
- Ezetimibe therapy: mechanism of action and clinical update.Vascular health and risk management · 2012Review
- Treatment of dyslipidemia in the elderly.Journal of geriatric cardiology : JGC · 2011Article
- What combination therapy with a statin, if any, would you recommend?Current atherosclerosis reports · 2011Review
- Effects of niacin on atherosclerosis and vascular function.Current opinion in cardiology · 2011Review
- Strategies to achieve target LDL levels.Current diabetes reports · 2010Article
- Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.Seminars in dialysisReview
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
19915218What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.